ID Source | ID |
---|---|
PubMed CID | 146361 |
SCHEMBL ID | 1553539 |
MeSH ID | M0113226 |
Synonym |
---|
4-methyl-4-aza-3-oxopregnane-20-carboxylate |
4-mapc |
(2s)-2-[(1r,3as,3bs,5ar,9ar,9bs,11as)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1h-indeno[5,4-f]quinolin-1-yl]propanoic acid |
4-azapregnane-20-carboxylic acid, 4-methyl-3-oxo-, (5alpha,20s)- |
4-methyl-4-aza-3-oxo-5alpha-pregnan-20-carboxylate |
92472-61-2 |
SCHEMBL1553539 |
2-(1,4a,6a-trimethyl-2-oxohexadecahydro-1h-indeno[5,4-f]quinolin-7-yl)propanoic acid |
DTXSID10919154 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (45.45) | 18.7374 |
1990's | 6 (54.55) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.92) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |